chr10-25175986-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_020752.3(GPR158):c.566A>T(p.Gln189Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000041 ( 0 hom. )
Consequence
GPR158
NM_020752.3 missense
NM_020752.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 2.13
Genes affected
GPR158 (HGNC:23689): (G protein-coupled receptor 158) Predicted to enable G protein-coupled receptor activity. Predicted to act upstream of or within G protein-coupled receptor signaling pathway and protein localization to plasma membrane. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3945284).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR158 | NM_020752.3 | c.566A>T | p.Gln189Leu | missense_variant | 1/11 | ENST00000376351.4 | NP_065803.2 | |
GPR158-AS1 | NR_027333.2 | n.291T>A | non_coding_transcript_exon_variant | 1/2 | ||||
GPR158 | XR_930512.4 | n.986A>T | non_coding_transcript_exon_variant | 1/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR158 | ENST00000376351.4 | c.566A>T | p.Gln189Leu | missense_variant | 1/11 | 1 | NM_020752.3 | ENSP00000365529 | P2 | |
GPR158-AS1 | ENST00000449643.1 | n.291T>A | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
GPR158 | ENST00000650135.1 | c.329A>T | p.Gln110Leu | missense_variant | 2/12 | ENSP00000498176 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152062Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
7
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 246914Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134058
GnomAD3 exomes
AF:
AC:
6
AN:
246914
Hom.:
AF XY:
AC XY:
2
AN XY:
134058
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1461024Hom.: 0 Cov.: 32 AF XY: 0.0000468 AC XY: 34AN XY: 726840
GnomAD4 exome
AF:
AC:
60
AN:
1461024
Hom.:
Cov.:
32
AF XY:
AC XY:
34
AN XY:
726840
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152062Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74274
GnomAD4 genome
AF:
AC:
7
AN:
152062
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | The c.566A>T (p.Q189L) alteration is located in exon 1 (coding exon 1) of the GPR158 gene. This alteration results from a A to T substitution at nucleotide position 566, causing the glutamine (Q) at amino acid position 189 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D
REVEL
Uncertain
Sift
Benign
.;D
Sift4G
Benign
.;T
Polyphen
0.45
.;P
Vest4
0.49
MutPred
0.41
.;Loss of disorder (P = 0.0406);
MVP
0.75
MPC
0.87
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at